Another extensive immunogenomic study of more than 10,000 tumors from TCGA demonstrated that patients with tumor types with IFN-γ dominant phenotype showed a less favorable survival, despite tumor higher lymphocytic infiltrate, a CD8 T cell-associated signature, and higher M1 content (44). This evidence concerns the gene CD8A and neoplasm.